Lantern Pharma Inc. · NASDAQ:LTRN
Empery Asset Management, LP's stake in Lantern Pharma Inc. fell to 4.99% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Oct 13, 2026
Empery Asset Management, LP's stake in Lantern Pharma Inc. fell to 4.99%, 755,891 shares, as a passive investor on Sep 30, 2026. Filed Oct 13, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 755,891
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 4.99% | 755,891 |
| Ryan M. Lane | 4.99% | 755,891 |
Source
Related
- Lantern Pharma Inc.
- Empery Asset Management, LP
- Lantern Pharma Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Jul 23, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · May 15, 2026
- Form 4 · Schalop Lee Troy · May 14, 2026
- Form 4 · Keyser D Jeffrey · May 14, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · Apr 16, 2026